Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changing Antimalarial Drug Sensitivities in Uganda.

Antimicrobial agents and chemotherapy - 1 Dec 2017

Rasmussen Stephanie A, Ceja Frida G, Conrad Melissa D, Tumwebaze Patrick K, Byaruhanga Oswald, Katairo Thomas, Nsobya Samuel L, Rosenthal Philip J, Cooper Roland A

Abstract excerpt

Dihydroartemisinin-piperaquine (DP) has demonstrated excellent efficacy for the treatment and prevention of malaria in Uganda. However, resistance to both components of this regimen has emerged in Southeast Asia. The efficacy of artemether-lumefantrine, the first-line regimen to treat malaria in Uganda, has also been excellent, but continued pressure may select for parasites with decreased sensitivity to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amodiaquine
Share to Artemisinins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chloroquine

Share to Ethanolamines

Share to Fluorenes

Share to Mefloquine

Share to Parasitic Sensitivity Tests

Share to Uganda

Source

Open in PubMed Open full text

Identifiers

PMID: 28923866
DOI: 10.1128/AAC.01516-17
PMCID: PMC5700361

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changing Antimalarial Drug Sensitivities in Uganda.PMID 28923866Read ↗

Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024.Semantic proximity Read ↗

Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.Semantic proximity Read ↗

Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children.Semantic proximity Read ↗

Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.Semantic proximity Read ↗

Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study.Semantic proximity Read ↗

Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24Semantic proximity Read ↗

Sustained high prevalence of multiple antimalarial drug resistance markers in Uganda in 2023-2024.Semantic proximity Read ↗

Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates.Semantic proximity Read ↗

Changes in susceptibility of <i>Plasmodium falciparum</i> to antimalarial drugs in Uganda over time: 2019-2024Semantic proximity Read ↗

Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria.Semantic proximity Read ↗

Limited Ability ofPlasmodium falciparum pfcrt,pfmdr1, andpfnhe1Polymorphisms To Predict QuinineIn VitroSensitivity or Clinical Effectiveness in UgandaSemantic proximity Read ↗

Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for The Treatment of Uncomplicated Plasmodium Falciparum Malaria and Prevalence of Molecular Markers Associated With Artemisinin and Partner Drug Resistance in UgandaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.